115 related articles for article (PubMed ID: 11689148)
21. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
[TBL] [Abstract][Full Text] [Related]
22. Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 2000; 46(1):69-76. PubMed ID: 10601800
[TBL] [Abstract][Full Text] [Related]
23. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways.
Kim JS; Lee JM; Chwae YJ; Kim YH; Lee JH; Kim K; Lee TH; Kim SJ; Park JH
Biochem Pharmacol; 2004 Apr; 67(8):1459-68. PubMed ID: 15041463
[TBL] [Abstract][Full Text] [Related]
25. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53.
Hayashi S; Ozaki T; Yoshida K; Hosoda M; Todo S; Akiyama S; Nakagawara A
Biochem Biophys Res Commun; 2006 Aug; 347(1):60-6. PubMed ID: 16815295
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
Lai MD; Lin WC; Sun YM; Chang FL
Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
[TBL] [Abstract][Full Text] [Related]
27. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation.
Mansouri A; Zhang Q; Ridgway LD; Tian L; Claret FX
Oncol Res; 2003; 13(6-10):399-404. PubMed ID: 12725530
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
Ping SY; Wu CL; Yu DS
Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
[TBL] [Abstract][Full Text] [Related]
30. Stabilization of p73 by nuclear IkappaB kinase-alpha mediates cisplatin-induced apoptosis.
Furuya K; Ozaki T; Hanamoto T; Hosoda M; Hayashi S; Barker PA; Takano K; Matsumoto M; Nakagawara A
J Biol Chem; 2007 Jun; 282(25):18365-18378. PubMed ID: 17452332
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.
da Silva GN; Filoni LT; Salvadori MC; Salvadori DMF
Pathol Oncol Res; 2018 Apr; 24(2):407-417. PubMed ID: 28577130
[TBL] [Abstract][Full Text] [Related]
32. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.
Shimodaira H; Yoshioka-Yamashita A; Kolodner RD; Wang JY
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2420-5. PubMed ID: 12601175
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
34. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
[TBL] [Abstract][Full Text] [Related]
35. [Establishment and characterization of a cis-diamminedichloro platinum-resistant human bladder cancer cell line].
Ochi J
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1045-52. PubMed ID: 1895616
[TBL] [Abstract][Full Text] [Related]
36. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.
Bilim V; Kasahara T; Hara N; Takahashi K; Tomita Y
Int J Cancer; 2003 Jan; 103(1):29-37. PubMed ID: 12455050
[TBL] [Abstract][Full Text] [Related]
37. Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin.
Sudhakar C; Jain N; Swarup G
FEBS J; 2008 May; 275(9):2200-13. PubMed ID: 18384375
[TBL] [Abstract][Full Text] [Related]
38. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
39. Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer.
Kawashima A; Nakayama M; Kakuta Y; Abe T; Hatano K; Mukai M; Nagahara A; Nakai Y; Oka D; Takayama H; Yoshioka T; Hoshida Y; Itatani H; Nishimura K; Nonomura N
Clin Cancer Res; 2011 Apr; 17(8):2561-9. PubMed ID: 21177407
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
